{
    "title": "Molecular Partners CEO considers partners, capital hike to boost cash",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4536936/Molecular-Partners-CEO-considers-partners-capital-hike-boost-cash.html",
    "date": "2017-05-24",
    "keywords": [
        "amstutz",
        "drug",
        "eye",
        "oncology",
        "johnson",
        "phase",
        "john",
        "miller",
        "paul",
        "arnold",
        "partner",
        "portfolio",
        "trial",
        "allergan",
        "lucentis",
        "disease",
        "money",
        "zurich",
        "pipeline",
        "biotechnology",
        "companys",
        "executive",
        "patrick",
        "cancer",
        "earlierstage",
        "billionaire",
        "hansjoerg",
        "wyss",
        "percent",
        "investor",
        "april",
        "interest",
        "cofounder",
        "interview",
        "thing",
        "number",
        "iii",
        "blindness",
        "roche",
        "novartis",
        "blockbuster",
        "rth258",
        "area",
        "abicipar",
        "winning",
        "eylea",
        "shot",
        "dosing",
        "schedule",
        "inflammation",
        "tenth",
        "delay",
        "formulation",
        "efficacy",
        "year",
        "developer",
        "gwen",
        "fyfe",
        "board",
        "month",
        "myeloma",
        "ii",
        "velcade",
        "mp0250s",
        "tumour",
        "budget",
        "partnership",
        "end",
        "takeover",
        "actelion",
        "optimism",
        "switzerland",
        "radar",
        "screen",
        "pursuit",
        "biotech",
        "boston",
        "francisco",
        "asset",
        "dilutive",
        "share",
        "balance",
        "aim",
        "cash",
        "position",
        "reporting",
        "editing",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}